News | August 04, 2022
Poly Medicure Q1FY23 consolidated PAT drops to Rs. 26.96 Cr
The company has reported total income of Rs. 253.42 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 253.42 crores during the period ended June 30, 2022.
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint, in these patients
The company has reported total income of Rs. 21.73 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 1463.03 crores during the period ended June 30, 2022.
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
The company has reported total income of Rs. 128.79 crores during the period ended June 30, 2022.
The news report stating Krsnaa Diagnostics has accepted Rs 100 crores of undisclosed income is incorrect and baseless.
he company has reported total income of Rs. 5478.62 crores during the period ended June 30, 2022.
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
GMM Pfaudler has reported total income of Rs. 767.73 crores during the period ended June 30, 2022
Subscribe To Our Newsletter & Stay Updated
